![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Batm Advanced Communications Ld | LSE:BVC | London | Ordinary Share | IL0010849045 | ORD ILS0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.60 | -2.91% | 20.00 | 20.00 | 20.90 | 20.60 | 20.00 | 20.60 | 34,413 | 16:24:10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Communications Services, Nec | 122.83M | -193k | -0.0004 | -500.00 | 89.82M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/5/2023 09:29 | Hi Emeraldzebra, unsure how much you have been following but the buyback occured on 20th Dec where the company bought 200,000 ordinary shares for a price of 22.488 | ![]() bigjon1 | |
11/5/2023 16:50 | Sorry I haven’t been following developments here as closely as I should - but what has happened to the buy back programme. ? Has it already been executed (or perhaps disbanded) ? Thanks. E. | ![]() emeraldzebra | |
10/5/2023 16:39 | Hopefully also very exciting news on both the 6th and 7th. | ![]() resistance1 | |
10/5/2023 16:35 | Excellent point Echo, I think there will be some very exciting things coming from Moti's presentation on the 7th | ![]() bigjon1 | |
10/5/2023 16:30 | On the other board, I referred to this as the 'starter's gun.' The Company understand what's at stake here, how misunderstood and therefore undervalued their share price is, so I think Moti and team will make sure that their focus will be on value: where they see it, how they can develop it and where they can exploit it. Go team.... | ![]() echoridge | |
10/5/2023 16:23 | The retail investor day is on the 7th BigJon. The capital markets day on the 6th for institutions. I think you need to register. It is very good practice IMHO that BATM are reaching out to retail investors as well as the big players. Often retail investors dont have their own session and can be excluded all together. Good for Moti. | ![]() resistance1 | |
10/5/2023 16:18 | Very encouraging to see how transparent BATM are being by updating the shareholders on their progress and the future strategy. These Investor Presentations are key to give shareholders confidence in the stock. Additionally it also gives investors the chance to have their questions answered - all in all, it will be a good opportunity to learn more about BATM's promising progress. I will be attending the Capital Markets day and hopefully I will see a few of you there! | ![]() bigjon1 | |
10/5/2023 15:48 | BATM attendance at the recent trade fair in BH was largely on behalf of the Israeli government. The company has been out pushing the sales and marketing side and hardly been idle. Our CEO, Moti Nagar, will be hosting an Investor Presentation via Investor Meet Company on Wednesday 7 June at 18:00 BST to provide an introduction to, and update on, BATM and our strategy with Q&A. Sign up here: | ![]() fse | |
10/5/2023 08:27 | Yes share price flat yesterday but decent volume. Assume Echo’s buyer(s) still snapping up undervalued shares. We need news to lift this up. | ![]() resistance1 | |
10/5/2023 08:15 | Morning everyone! Let's see what BATM price action has in store for us today. V quiet day yesterday, hopefully we get some more volatility today - some RNS news would be lovely. | ![]() bigjon1 | |
09/5/2023 17:23 | As a lovely - and very late - print of a 1/4million goes through at 25.25p to take us to one and a quarter million shares for the day. | ![]() echoridge | |
09/5/2023 15:58 | Looks like we're going to trade 1m shares today the hard way | ![]() echoridge | |
09/5/2023 12:25 | Absolutely agreed jon, Zvi may be a bit of a lightning rod for controversy, but all publicity is good publicity. And with his expertise in the medical division and contributions to the ADOR deal, BATM would be foolish to let him go. Plus. Here's hoping BATM can push through the barrier and hit that 30 mark! | tradeterminator01 | |
09/5/2023 11:14 | Although Zvi has been quite a controversial figure, I think it is positive that BATM have kept him around. As mentioned before, Zvi has extensive knowledge of the medical division and has been pivotal in the ADOR deal. His connection will also be of use for BATM - he is a valuable person for them to keep around. Anyway, I am looking forward to this week of trading, hopefully BATM can start to hit the 30 mark | ![]() bigjon1 | |
08/5/2023 17:57 | pockstones8 May '23 - 16:59 - 22754 of 22754 (Filtered) | ![]() fse | |
08/5/2023 14:07 | From BATM twitter. | ![]() fse | |
08/5/2023 11:45 | Doesn't sound like they have got any new contracts yet, just trying to establish contacts in the balkans. | ![]() paulisi | |
08/5/2023 10:46 | FSE, It's great to see Moti and Zvi taking charge and bringing new energy to the scene. While BATM has a strong track record in IP development, the shift in management was definitely necessary to strengthen their sales and marketing efforts. They potential to revolutionize the medical profession by delivering rapid molecular diagnostics and matching conditions with appropriate treatments using AI, the ADOR diagnostics program will definitely be a game changer. With the budgetary constraints faced by healthcare systems worldwide, the combination of molecular diagnostics and AI could certainly alleviate the pressure on GPs, nurses, and hospitals. It's exciting to see how technology can improve patient outcomes and help healthcare professionals deliver the best care possible, even in the face of limited resources. I really think that current social and economic trends will allow BATM to implement their business model nicely. | tradeterminator01 | |
08/5/2023 07:10 | https://www.dnevnik. | ![]() kooba | |
04/5/2023 08:21 | The global in-vitro diagnostics market is expected to reach $130bn by 2030. The growth is being driven by a rising prevalence of chronic and infectious diseases, increased research funding, and demand for point-of-care testing. This news is very exciting for ADOR’s multiplexing isothermal amplification technology, which is set to revolutionise the way small- to medium-sized laboratories test for infectious diseases. | ![]() wizzkid211 | |
04/5/2023 06:19 | Looks like they thought twice about the photo with Zvi!Deleted that tweet replaced with one just of Moti.I didn't think it was the best look.https://twitter | ![]() kooba | |
03/5/2023 14:37 | Very Happy to see Moti and Zvi out on the scene. It's all been a lot more active recently. The management shift was planned a long time ago as whilst BATM have a great record on IP development the same can not be said for Sales and Marketing. Zvi is very much needed in the medical division particularly as they are in the closing stages for ADOR to release a new very radical diagnostics platform. The objective for ADOR was to deliver a molecular diagnostic solution with rapid results and then match the condition with the appropriate treatment. This is what AI can achieve for the medical profession. As you all know in the UK after the nurses strike etc that the budget simply will not stretch to provide the services needed. Molecular Diagnostics combined with AI will/could take significant pressure off GP's nurses and Hospitals generally. | ![]() fse | |
03/5/2023 12:06 | ZVI MAROM still in the picture... | ![]() wizzkid211 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions